Viewing Study NCT04465292


Ignite Creation Date: 2025-12-24 @ 3:59 PM
Ignite Modification Date: 2025-12-25 @ 2:02 PM
Study NCT ID: NCT04465292
Status: UNKNOWN
Last Update Posted: 2020-07-10
First Post: 2020-05-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: The Effects of Tildrakizumab in Treatment of Bullous Pemphigoid
Sponsor: Brigham and Women's Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module